|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
BRPI0614805A2
(pt)
|
2005-08-10 |
2011-04-12 |
Univ Johns Hopkins |
poliaminas úteis como produtos terapêuticos antiparasìticos e anticáncer e como inibidores de demetilase lisina-especìficos
|
|
JP2010523685A
(ja)
|
2007-04-13 |
2010-07-15 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
リジン特異的デメチラーゼ阻害剤
|
|
EP2361242B1
(en)
|
2008-10-17 |
2018-08-01 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
US8993808B2
(en)
|
2009-01-21 |
2015-03-31 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
US8389580B2
(en)
|
2009-06-02 |
2013-03-05 |
Duke University |
Arylcyclopropylamines and methods of use
|
|
JPWO2010143582A1
(ja)
|
2009-06-11 |
2012-11-22 |
公立大学法人名古屋市立大学 |
フェニルシクロプロピルアミン誘導体及びｌｓｄ１阻害剤
|
|
AU2010284221B2
(en)
|
2009-08-18 |
2016-09-22 |
Casero, Robert A |
(bis) urea and (bis) thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
US8859555B2
(en)
|
2009-09-25 |
2014-10-14 |
Oryzon Genomics S.A. |
Lysine Specific Demethylase-1 inhibitors and their use
|
|
US8946296B2
(en)
|
2009-10-09 |
2015-02-03 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
|
|
RU2599248C2
(ru)
|
2010-04-19 |
2016-10-10 |
Оризон Дженомикс С.А. |
Лизинспецифические ингибиторы деметилазы-1 и их применение
|
|
BR112012027062B8
(pt)
|
2010-04-20 |
2021-05-25 |
Fond Ieo |
composto, processo para a preparação de um composto e usos do mesmo
|
|
US9006449B2
(en)
|
2010-07-29 |
2015-04-14 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as LSD1 inhibitors
|
|
ME03085B
(me)
|
2010-07-29 |
2019-01-20 |
Oryzon Genomics Sa |
Demetilaza inhibitori lsd1 zasnovani na arilciklopropilaminu i njihova medicinska primjena
|
|
WO2012034116A2
(en)
|
2010-09-10 |
2012-03-15 |
The Johns Hopkins University |
Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
|
|
US9061966B2
(en)
|
2010-10-08 |
2015-06-23 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
WO2012071469A2
(en)
|
2010-11-23 |
2012-05-31 |
Nevada Cancer Institute |
Histone demethylase inhibitors and uses thereof for treatment o f cancer
|
|
CN103857393B
(zh)
|
2011-03-25 |
2016-08-17 |
葛兰素史密斯克莱知识产权（第2号）有限公司 |
环丙基胺作为lsd1抑制剂
|
|
UA114406C2
(uk)
|
2011-08-09 |
2017-06-12 |
Такеда Фармасьютікал Компані Лімітед |
Похідні циклопропанаміну як інгібітори lsd1
|
|
EP2744330B1
(en)
|
2011-08-15 |
2020-07-15 |
University of Utah Research Foundation |
Substituted (e)-n'-(1-phenylethylidene) benzohydrazide analogs as histone demethylase inhiitors
|
|
WO2013033688A1
(en)
|
2011-09-01 |
2013-03-07 |
The Brigham And Women's Hospital, Inc. |
Treatment of cancer
|
|
BR112014009306B1
(pt)
|
2011-10-20 |
2021-07-20 |
Oryzon Genomics S.A. |
Compostos de (hetero)aril ciclopropilamina como inibidores de lsd1
|
|
BR112014009238B1
(pt)
|
2011-10-20 |
2022-08-09 |
Oryzon Genomics S.A. |
Compostos de (hetero)aril ciclopropilamina, seus usos e composições farmacêuticas
|
|
EP2907802B1
(en)
|
2012-10-12 |
2019-08-07 |
Takeda Pharmaceutical Company Limited |
Cyclopropanamine compound and use thereof
|
|
JP6238908B2
(ja)
|
2012-11-28 |
2017-11-29 |
京都府公立大学法人 |
リシン構造を有するｌｓｄ１選択的阻害薬
|
|
US9144555B2
(en)
|
2012-11-30 |
2015-09-29 |
Darlene E. McCord |
Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
|
|
EP2740474A1
(en)
|
2012-12-05 |
2014-06-11 |
Instituto Europeo di Oncologia S.r.l. |
Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
|
CN103054869A
(zh)
|
2013-01-18 |
2013-04-24 |
郑州大学 |
含三唑基的氨基二硫代甲酸酯化合物在制备以lsd1为靶标药物中的应用
|
|
WO2014164867A1
(en)
|
2013-03-11 |
2014-10-09 |
Imago Biosciences |
Kdm1a inhibitors for the treatment of disease
|
|
EP3010915B1
(en)
|
2013-06-19 |
2019-05-08 |
University of Utah Research Foundation |
Substituted (3-(5-chloro-2-hydroxyphenyl)-1-benzoyl-1h-pyrazole compounds as histone demethylase inhibitors
|
|
CN103319466B
(zh)
|
2013-07-04 |
2016-03-16 |
郑州大学 |
含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用
|
|
MX383590B
(es)
|
2013-08-06 |
2025-03-11 |
Imago Biosciences Inc |
Inhibidores de kdm1a para el tratamiento de enfermedades.
|
|
US9186391B2
(en)
|
2013-08-29 |
2015-11-17 |
Musc Foundation For Research Development |
Cyclic peptide inhibitors of lysine-specific demethylase 1
|
|
WO2015031564A2
(en)
|
2013-08-30 |
2015-03-05 |
University Of Utah |
Substituted-1h-benzo[d]imidazole series compounds as lysine-specfic demethylase 1 (lsd1) inhibitors
|
|
LT3080100T
(lt)
|
2013-12-11 |
2023-02-27 |
Celgene Quanticel Research, Inc. |
Lizinui specifinės demetilazės-1 inhibitoriai
|
|
EP3102034A4
(en)
|
2014-02-07 |
2017-07-12 |
MUSC Foundation For Research Development |
Aminotriazole- and aminotetrazole-based kdm1a inhibitors as epigenetic modulators
|
|
PT3105226T
(pt)
|
2014-02-13 |
2019-11-06 |
Incyte Corp |
Ciclopropilaminas como inibidores de lsd1
|
|
WO2015123437A1
(en)
|
2014-02-13 |
2015-08-20 |
Incyte Corporation |
Cyclopropylamines as lsd1 inhibitors
|
|
TW201613860A
(en)
|
2014-02-13 |
2016-04-16 |
Incyte Corp |
Cyclopropylamines as LSD1 inhibitors
|
|
ME03654B
(me)
|
2014-02-13 |
2020-07-20 |
Incyte Corp |
Ciklopropilamini kao lsd1 inhibitori
|
|
WO2015134973A1
(en)
|
2014-03-07 |
2015-09-11 |
The Johns Hopkins University |
Inhibitors of histone lysine specific demethylase (lsd1) and histone deacetylases (hdacs)
|
|
CN103893163B
(zh)
|
2014-03-28 |
2016-02-03 |
中国药科大学 |
2-([1，1′-联苯]-4-基)2-氧代乙基4-((3-氯-4-甲基苯基)氨基)-4-氧代丁酸酯在制备lsd1抑制剂药物中的应用
|
|
BR112016023382B1
(pt)
|
2014-04-11 |
2023-01-10 |
Takeda Pharmaceutical Company Limited |
Composto, medicamento, e, uso de um composto
|
|
CN103961340B
(zh)
|
2014-04-30 |
2019-06-25 |
南通中国科学院海洋研究所海洋科学与技术研究发展中心 |
一类lsd1抑制剂及其应用
|
|
US9255097B2
(en)
|
2014-05-01 |
2016-02-09 |
Quanticel Pharmaceuticals, Inc. |
Inhibitors of lysine specific demethylase-1
|
|
EP3148974B1
(en)
|
2014-05-30 |
2018-09-26 |
Istituto Europeo di Oncologia S.r.l. |
Cyclopropylamine compounds as histone demethylase inhibitors
|
|
CN104119280B
(zh)
|
2014-06-27 |
2016-03-16 |
郑州大学 |
含氨基类脲与端炔结构单元的嘧啶衍生物、制备方法及应用
|
|
US10011583B2
(en)
|
2014-06-27 |
2018-07-03 |
Celgene Quanticel Research, Inc. |
Inhibitors of lysine specific demethylase-1
|
|
SI3511319T1
(sl)
|
2014-07-03 |
2023-10-30 |
Celgene Quanticel Research, Inc. |
Inhibitorji lizin specifične demetilaze-1
|
|
ES2905280T3
(es)
|
2014-07-03 |
2022-04-07 |
Celgene Quanticel Res Inc |
Inhibidores de la desmetilasa 1 específica de lisina
|
|
TW201613925A
(en)
|
2014-07-10 |
2016-04-16 |
Incyte Corp |
Imidazopyrazines as LSD1 inhibitors
|
|
WO2016007722A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
WO2016007731A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Imidazopyridines and imidazopyrazines as lsd1 inhibitors
|
|
WO2016007727A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
CN107074787B
(zh)
|
2014-09-05 |
2020-10-27 |
赛尔基因昆蒂赛尔研究公司 |
赖氨酸特异性脱甲基酶-1的抑制剂
|
|
EP2993175A1
(en)
|
2014-09-05 |
2016-03-09 |
IEO - Istituto Europeo di Oncologia Srl |
Thienopyrroles as histone demethylase inhibitors
|
|
EP3250552B1
(en)
|
2015-01-30 |
2019-03-27 |
Genentech, Inc. |
Therapeutic compounds and uses thereof
|
|
LT3256218T
(lt)
|
2015-02-12 |
2025-02-10 |
Imago Biosciences Inc. |
Kdm1a inhibitorius ir jo panaudojimas terapijoje
|
|
CN106146361A
(zh)
|
2015-03-16 |
2016-11-23 |
四川大学 |
茚-1-亚基磺酰基苯甲酰肼衍生物及其制备方法和用途
|
|
AU2016243939B2
(en)
|
2015-04-03 |
2020-09-03 |
Incyte Holdings Corporation |
Heterocyclic compounds as LSD1 inhibitors
|
|
CN106045862B
(zh)
|
2015-04-10 |
2019-04-23 |
上海迪诺医药科技有限公司 |
环丙胺类螺(杂)环化合物、其药物组合物及应用
|
|
WO2016172496A1
(en)
|
2015-04-23 |
2016-10-27 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitors and uses thereof
|
|
EP3090998A1
(en)
|
2015-05-06 |
2016-11-09 |
F. Hoffmann-La Roche AG |
Solid forms
|
|
WO2017004519A1
(en)
|
2015-07-02 |
2017-01-05 |
University Of Utah Research Foundation |
Substituted benzohydrazide analogs as histone demethylase inhibitors
|
|
KR102710120B1
(ko)
|
2015-08-12 |
2024-09-27 |
인사이트 홀딩스 코포레이션 |
Lsd1 저해제의 염
|
|
SMT202100044T1
(it)
|
2015-11-05 |
2021-05-07 |
Celgene Quanticel Research Inc |
Composizioni comprendenti un inibitore della demetilasi-1 specifica per la lisina avente un anello pirimidinico e suo uso nel trattamento del cancro
|
|
US10059668B2
(en)
|
2015-11-05 |
2018-08-28 |
Mirati Therapeutics, Inc. |
LSD1 inhibitors
|
|
PL3381896T3
(pl)
|
2015-11-27 |
2023-05-08 |
Taiho Pharmaceutical Co., Ltd. |
Związek bifenylowy lub jego sól
|
|
WO2017109061A1
(en)
|
2015-12-23 |
2017-06-29 |
Ieo - Istituto Europeo Di Oncologia S.R.L. |
Spirocyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a
|
|
EP3397616B1
(en)
|
2015-12-29 |
2020-06-10 |
Mirati Therapeutics, Inc. |
Lsd1 inhibitors
|
|
SG11201805451TA
(en)
|
2015-12-30 |
2018-07-30 |
Novartis Ag |
Immune effector cell therapies with enhanced efficacy
|
|
CN110267945A
(zh)
|
2016-03-01 |
2019-09-20 |
诺华股份有限公司 |
氰基取代的吲哚化合物及其作为lsd1抑制剂的用途
|
|
CN107200706A
(zh)
|
2016-03-16 |
2017-09-26 |
中国科学院上海药物研究所 |
一类氟取代的环丙胺类化合物及其制备方法、药物组合物和用途
|
|
US20170283397A1
(en)
|
2016-03-31 |
2017-10-05 |
University Of Utah Research Foundation |
Substituted 1-h-indol-3-yl-benzamide and 1, 1'-biphenyl analogs as histone demethylase inhibitors
|
|
US11352322B2
(en)
|
2016-05-09 |
2022-06-07 |
Jubilant Epicore LLC |
Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors
|
|
EP3246330A1
(en)
|
2016-05-18 |
2017-11-22 |
Istituto Europeo di Oncologia S.r.l. |
Imidazoles as histone demethylase inhibitors
|
|
CN107513068A
(zh)
|
2016-06-16 |
2017-12-26 |
中国科学院上海药物研究所 |
一种具有fgfr抑制活性的新型化合物及其制备和应用
|
|
CN106478639B
(zh)
|
2016-09-05 |
2018-09-18 |
郑州大学 |
嘧啶并1,2,4–三氮唑类的lsd1抑制剂、其制备方法及应用
|
|
CN106432248B
(zh)
|
2016-09-27 |
2018-11-27 |
郑州大学 |
含嘧啶并三氮唑类lsd1抑制剂、其制备方法及应用
|
|
ES2961499T3
(es)
|
2016-10-26 |
2024-03-12 |
Constellation Pharmaceuticals Inc |
Inhibidores de LSD1 y usos médicos de los mismos
|
|
WO2018081342A1
(en)
|
2016-10-26 |
2018-05-03 |
Constellation Pharmaceuticals, Inc. |
Lsd1 inhibitors and uses thereof
|
|
AU2018213637B2
(en)
|
2017-01-24 |
2022-01-27 |
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. |
LSD1 inhibitor and preparation method and application thereof
|
|
CN106831489B
(zh)
|
2017-03-23 |
2018-04-17 |
郑州大学 |
苯环丙胺酰腙类化合物、制备方法及其应用
|
|
CN106928235A
(zh)
|
2017-05-03 |
2017-07-07 |
郑州大学 |
含嘧啶并三氮唑类lsd1抑制剂、其制备方法及应用
|
|
CN110914265B
(zh)
|
2017-05-15 |
2022-12-23 |
密歇根大学董事会 |
作为lsd-1抑制剂的吡咯并[2,3-c]吡啶和相关类似物
|
|
MX391414B
(es)
|
2017-05-26 |
2025-03-21 |
Taiho Pharmaceutical Co Ltd |
Compuesto novedoso de bifenilo o sal del mismo.
|
|
KR20180134675A
(ko)
|
2017-06-09 |
2018-12-19 |
한미약품 주식회사 |
시클로프로필아민 유도체 화합물 및 이의 용도
|
|
UY37774A
(es)
|
2017-06-19 |
2019-01-31 |
Novartis Ag |
Compuestos 5-cianoindol sustituidos y usos de los mismos
|
|
JP2020152641A
(ja)
|
2017-07-07 |
2020-09-24 |
国立研究開発法人理化学研究所 |
リジン特異的脱メチル化酵素１阻害活性を有する新規化合物、その製造方法及びその用途
|
|
SI3661510T1
(sl)
|
2017-08-03 |
2025-03-31 |
Oryzon Genomics, S.A. |
Postopki zdravljenja vedenjskih sprememb
|